SCANDMEDICAL SOLDK-040 (Germany) Performance
| K41 Stock | 0.83 0.03 3.49% |
SCANDMEDICAL SOLDK-040 has a performance score of 3 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of 0.12, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SCANDMEDICAL SOLDK-040's returns are expected to increase less than the market. However, during the bear market, the loss of holding SCANDMEDICAL SOLDK-040 is expected to be smaller as well. SCANDMEDICAL SOLDK 040 at this time owns a risk of 3.22%. Please validate SCANDMEDICAL SOLDK 040 downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to decide if SCANDMEDICAL SOLDK 040 will be following its current price history.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in SCANDMEDICAL SOLDK 040 are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, SCANDMEDICAL SOLDK-040 may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
SCANDMEDICAL |
SCANDMEDICAL SOLDK-040 Relative Risk vs. Return Landscape
If you would invest 78.00 in SCANDMEDICAL SOLDK 040 on August 27, 2024 and sell it today you would earn a total of 5.00 from holding SCANDMEDICAL SOLDK 040 or generate 6.41% return on investment over 90 days. SCANDMEDICAL SOLDK 040 is currently producing 0.1458% returns and takes up 3.2212% volatility of returns over 90 trading days. Put another way, 28% of traded stocks are less volatile than SCANDMEDICAL, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SCANDMEDICAL SOLDK-040 Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SCANDMEDICAL SOLDK-040's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SCANDMEDICAL SOLDK 040, and traders can use it to determine the average amount a SCANDMEDICAL SOLDK-040's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0453
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | K41 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.22 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average SCANDMEDICAL SOLDK-040 is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SCANDMEDICAL SOLDK-040 by adding it to a well-diversified portfolio.
About SCANDMEDICAL SOLDK-040 Performance
By analyzing SCANDMEDICAL SOLDK-040's fundamental ratios, stakeholders can gain valuable insights into SCANDMEDICAL SOLDK-040's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SCANDMEDICAL SOLDK-040 has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SCANDMEDICAL SOLDK-040 has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about SCANDMEDICAL SOLDK 040 performance evaluation
Checking the ongoing alerts about SCANDMEDICAL SOLDK-040 for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SCANDMEDICAL SOLDK 040 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SCANDMEDICAL SOLDK-040 has some characteristics of a very speculative penny stock | |
| SCANDMEDICAL SOLDK-040 had very high historical volatility over the last 90 days |
- Analyzing SCANDMEDICAL SOLDK-040's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SCANDMEDICAL SOLDK-040's stock is overvalued or undervalued compared to its peers.
- Examining SCANDMEDICAL SOLDK-040's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SCANDMEDICAL SOLDK-040's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SCANDMEDICAL SOLDK-040's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SCANDMEDICAL SOLDK-040's stock. These opinions can provide insight into SCANDMEDICAL SOLDK-040's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SCANDMEDICAL Stock analysis
When running SCANDMEDICAL SOLDK-040's price analysis, check to measure SCANDMEDICAL SOLDK-040's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCANDMEDICAL SOLDK-040 is operating at the current time. Most of SCANDMEDICAL SOLDK-040's value examination focuses on studying past and present price action to predict the probability of SCANDMEDICAL SOLDK-040's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCANDMEDICAL SOLDK-040's price. Additionally, you may evaluate how the addition of SCANDMEDICAL SOLDK-040 to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |